Home/Filings/4/0001209191-15-077687
4//SEC Filing

STERIS CORP 4

Accession 0001209191-15-077687

CIK 0000815065operating

Filed

Nov 1, 7:00 PM ET

Accepted

Nov 2, 4:08 PM ET

Size

27.8 KB

Accession

0001209191-15-077687

Insider Transaction Report

Form 4
Period: 2015-11-02
Transactions
  • Disposition to Issuer

    Career Restricted Stock Units

    2015-11-022,3620 total
    Common Shares, No Par Value (2,362 underlying)
  • Disposition to Issuer

    Common Shares, No Par Value

    2015-11-0234,1310 total
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-023,3870 total
    Exercise: $27.68Exp: 2017-07-27Common Shares, No Par Value (3,387 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-023,6090 total
    Exercise: $28.08Exp: 2019-07-31Common Shares, No Par Value (3,609 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-022,7440 total
    Exercise: $34.17Exp: 2018-07-31Common Shares, No Par Value (2,744 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-023,1210 total
    Exercise: $31.61Exp: 2021-08-03Common Shares, No Par Value (3,121 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-024,1100 total
    Exercise: $64.05Exp: 2025-08-31Common Shares, No Par Value (4,110 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-023,1330 total
    Exercise: $32.34Exp: 2020-08-04Common Shares, No Par Value (3,133 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-023,2180 total
    Exercise: $32.36Exp: 2022-08-03Common Shares, No Par Value (3,218 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2015-11-024,5840 total
    Exercise: $51.53Exp: 2024-08-06Common Shares, No Par Value (4,584 underlying)
Footnotes (10)
  • [F1]Represents shares of STERIS Corporation ("STERIS") disposed of pursuant to merger of a wholly-owned subsidiary of STERIS plc ("New STERIS") with and into STERIS, with STERIS surviving the merger as a wholly-owned subsidiary of New STERIS (the "Merger"), in exchange for ordinary shares of New STERIS, which was consummated simultaneous with and conditioned on New STERIS' acquisition of Synergy Health plc by commencing a "recommended offer" under English law. At the effective time of the Merger, each STERIS common share was cancelled and converted into the right to receive one New STERIS ordinary share.
  • [F10]At the effective time of the Merger, each STERIS career restricted stock unit was cancelled and converted to a New STERIS career restricted stock unit, subject to the same terms and conditions that were applicable to the original STERIS career restricted stock unit. These New STERIS career restricted stock units are fully vested and will be settled in New STERIS ordinary shares six months after the cessation of the Director's Board service.
  • [F2]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,387 ordinary shares of New STERIS for $27.68 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
  • [F3]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 2,744 ordinary shares of New STERIS for $34.17 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
  • [F4]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,609 ordinary shares of New STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
  • [F5]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,133 ordinary shares of New STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
  • [F6]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,121 ordinary shares of New STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
  • [F7]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 3,218 ordinary shares of New STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
  • [F8]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 4,584 ordinary shares of New STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original STERIS option.
  • [F9]This option is fully vested. This option was assumed by New STERIS in the Merger and converted to an option to purchase 4,110 ordinary shares of New STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original STERIS option.

Issuer

STERIS CORP

CIK 0000815065

Entity typeoperating
IncorporatedOH

Related Parties

1
  • filerCIK 0000815065

Filing Metadata

Form type
4
Filed
Nov 1, 7:00 PM ET
Accepted
Nov 2, 4:08 PM ET
Size
27.8 KB